She starts ECCT as treatment for Mediastinal Cancer and shrink the mass to half the size in 9 months

Female, 68 years old, Primary mediastinal giant cell tumor

A mediastinal giant cell tumor is a rare, aggressive benign tumor that usually develops near a joint at the end of a bone. Most occur in the long bones of the legs and arms in young adults when skeletal bone growth is complete. Giant cell tumors have a high recurrence rate and a potential for aggressive behavior. The metastatic forms of giant cell tumors are known as malignant sarcomas.

In January 2022, the patient was in a weakened condition with symptoms including dry throat, cough, fatigue, shortness of breath, and hard lumps on her chest. Based on the CT Scan of the chest with contrast, the results showed a cystic mixed solid anterior mediastinal mass, multiseptated with a calcified component, especially in the septations. There was an increase in solid components and septa, raising concern for malignant thymic carcinoma.

The mass measured about 9x11x11 cm, extending to the left and protruding exophytically anteriorly to reach the anterior thorax wall. It caused destruction of the left anterior 1 and 2 ribs and invaded the intercostal muscles adjacent to the mass. Additionally, it pushed the right and left pectoralis anteriorly and attached to the left supranterior pericardium with minimal pleural effusion. Due to the size and location, treatment for Mediastinal Cancer like surgery is not advisable till the tumor reach a smaller size. The patient then underwent radiotherapy for 30 sessions hoping to shrink the size and continue with ECCT post-radiotherapy.

Her Treatment History:

- 15th session: CT scan showed progressive tumors.

- 20th session: Radiotherapy was stopped due to the tumor's increased size and lack of response to treatment.

- Started ECCT post-radiotherapy.

After using ECCT for 9 months, the CT Scan results showed a decrease in the size of the tumor mass from 9x11x11 cm to 8.1x8.2x8 cm compared to the previous scan. The patient's current condition has significantly improved, with reduced complaints of coughing and fatigue, improved breathing, and visibly smaller lump.

Throughout her journey, there was no inflammation occurring in the tumor area, and neither chemotherapy nor surgery were performed pre and post radiotherapy. The patient's key to success was her strong will and high discipline in following the given schedule, ensuring she had enough nutrition for her body to excrete the dead cells over time. Additionally, her thorax functions showed no abnormalities.

患者为女性，年龄68岁。 原发性纵隔巨细胞肿瘤。她开始电容癌症疗法 (ECCT) 作为纵隔癌的治疗方法，并在 9 个月内将肿块缩小了一半！

纵隔巨细胞肿瘤是一种罕见而侵袭性的良性肿瘤，通常在骨头末端的关节附近发展。大多数发生在骨骼生长完全结束后的年轻成年人的长骨，如腿部和手臂。巨细胞肿瘤有很高的复发率和潜在的侵袭性行为。巨细胞肿瘤的转移形式称为恶性肉瘤。

2022年1月，患者身体状况较差，症状包括喉咙干燥、咳嗽、疲劳、气短和胸部有硬块。基于胸部带对比剂的CT扫描结果显示，一个囊性混合固体前纵隔肿块，多隔壁内有钙化成分，尤其在隔壁内。固体成分和隔壁内有所增加，引起对恶性胸腺癌的担忧。肿块尺寸约为9x11x11厘米，向左侧延伸并向前突出达到前胸壁。它破坏了左侧的1和2号肋骨，并侵犯了贴近肿块的肋间肌肉。此外，它将右侧和左侧胸大肌向前推挤，并与左侧上前心包相连，伴有少量胸腔积液。由于肿块的大小和位置，手术暂时不宜进行，需要等待肿瘤缩小到一定尺寸后再考虑手术。于是，患者接受了30次放射疗法，希望缩小肿瘤的大小，并在放疗后继续使用ECCT。

在接受了9个月的 CCT 治疗后，CT扫描结果显示，与之前的扫描相比，肿瘤质量从9x11x11厘米缩小至8.1x8.2x8厘米。患者目前的状况显著改善，咳嗽和疲劳症状减轻，呼吸改善，并且肿块显著变小。

在整个治疗过程中，肿瘤区域没有发生炎症，既没有在放射疗法前后进行化疗，也没有进行手术。患者成功的关键在于她坚强的意志力和高度纪律性，她遵循所给定的时间表，确保她摄取足够的营养以促进身体逐渐排出死亡细胞。此外，她的胸部功能没有异常。